Neuroimaging Reader Study on Clinical Sensitivity and Specificity Using Synthetic MRI Based on MR Quantification

References

1. 1.↵
   1. Warntjes JBM,
   2. Leinhard OD,
   3. West J, et al

   . Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320–29 doi:10.1002/mrm.21635 pmid:18666127

   CrossRefPubMed
2. 2.↵
   1. Ma D,
   2. Gulani V,
   3. Seiberlich N, et al

   . Magnetic resonance fingerprinting. Nature 2013;495:187–92 doi:10.1038/nature11971 pmid:23486058

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Deoni SCL,
   2. Rutt BK,
   3. Peters TM

   . High-resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2. Magn Reson Med 2005;53:237–41 doi:10.1002/mrm.20314 pmid:15690526

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Kvernby S,
   2. Warntjes MJ,
   3. Haraldsson H, et al

   . Simultaneous three-dimensional myocardial T1 and T2 mapping in one breath hold with 3D-QALAS. J Cardiovasc Magn Reson 2014;16:102 doi:10.1186/s12968-014-0102-0 pmid:25526880

   CrossRefPubMed
5. 5.↵
   1. Kvernby S,
   2. Warntjes M,
   3. Engvall J, et al

   . Clinical feasibility of 3D-QALAS-single breath-hold 3D myocardial T1- and T2-mapping. Magn Reson Imaging 2017;38:13–20 doi:10.1016/j.MRI.2016.12.014 pmid:27998745

   CrossRefPubMed
6. 6.↵
   1. Fujita S,
   2. Hagiwara A,
   3. Hori M, et al

   . Three-dimensional high-resolution simultaneous quantitative mapping of the whole brain with 3D-QALAS: an accuracy and repeatability study. Magn Reson Imaging 2019;63:235–43 doi:10.1016/j.MRI.2019.08.031 pmid:31445118

   CrossRefPubMed
7. 7.↵
   1. Granberg T,
   2. Uppman M,
   3. Hashim F, et al

   . Clinical feasibility of synthetic MRI in multiple sclerosis: a diagnostic and volumetric validation study. AJNR Am J Neuroradiol 2016;37:1023–29 doi:10.3174/ajnr.A4665 pmid:26797137

   Abstract/FREE Full Text
8. 8.↵
   1. Hagiwara A,
   2. Warntjes M,
   3. Hori M, et al

   . SyMRI of the brain: rapid quantification of relaxation rates and proton density, with synthetic MRI, automatic brain segmentation, and myelin measurement. Invest Radiology 2017;52:647–57 doi:10.1097/RLI.0000000000000365 pmid:28257339

   CrossRefPubMed
9. 9.↵
   1. Bobman SA,
   2. Riederer SJ,
   3. Lee JN, et al

   . Cerebral magnetic resonance image synthesis. AJR AJNR Am J Neuroradiol 1985;6:265–69
10. 10.↵
    1. Tanenbaum LN,
    2. Tsiouris AJ,
    3. Johnson AN, et al

    . Synthetic MRI for clinical neuroimaging: results of the Magnetic Resonance Image Compilation (MAGiC) prospective, multicenter, multireader trial. AJNR Am J Neuroradiol 2017;38:1103–10 doi:10.3174/ajnr.A5227 pmid:28450439

    Abstract/FREE Full Text
11. 11.↵
    1. Aymerich FX,
    2. Auger C,
    3. Alonso J, et al

    . Assessment of 2D conventional and synthetic MRI in multiple sclerosis. Neuroradiology 2022;64:2315–22 doi:10.1007/s00234-022-02973-2 pmid:35583667

    CrossRefPubMed
12. 12.↵
    1. Forslin Y,
    2. Bergendal Å,
    3. Hashim F, et al

    . Detection of leukocortical lesions in multiple sclerosis and their association with physical and cognitive impairment: a comparison of conventional and synthetic phase-sensitive inversion recovery MRI. AJNR Am J Neuroradiol 2018;39:1995–2000 doi:10.3174/ajnr.A5815 pmid:30262646

    Abstract/FREE Full Text
13. 13.↵
    1. Betts AM,
    2. Leach JL,
    3. Jones BV, et al

    . Brain imaging with synthetic MR in children: clinical quality assessment. Neuroradiology 2016;58:1017–26 doi:10.1007/s00234-016-1723-9 pmid:27438803

    CrossRefPubMed
14. 14.↵
    1. Atighechi S,
    2. Zolfaghari A,
    3. Baradaranfar M, et al

    . Estimation of sensitivity and specificity of brain magnetic resonance imaging and single photon emission computed tomography in the diagnosis of olfactory dysfunction after head traumas. Am J Rhinol Allergy 2013;27:403–06 doi:10.2500/ajra.2013.27.3931 pmid:24119604

    CrossRefPubMed
15. 15.↵
    1. Wollman DE,
    2. Prohovnik I

    . Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer’s disease. Dialogues Clin Neurosci 2003;5:89–99 doi:10.1080/19585969.2022.12130515

    CrossRefPubMed
16. 16.↵
    1. Sabol Z,
    2. Resić B,
    3. Juraski R, et al

    . Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study. Croat Med J 2011;52:488–96 doi:10.3325/cmj.2011.52.488 pmid:21853543

    CrossRefPubMed
17. 17.↵
    1. Hagiwara A,
    2. Hori M,
    3. Yokoyama K, et al

    . Synthetic MRI in the detection of multiple sclerosis plaques. AJNR Am J Neuroradiol 2017;38:257–63 doi:10.3174/ajnr.A5012 pmid:27932506

    Abstract/FREE Full Text
18. 18.↵
    1. Nakaya M,
    2. Hagiwara A,
    3. Hori M, et al

    . Synthetic double inversion recovery (DIR) and phase-sensitive inversion recovery (PSIR) images showed better delineation of multiple sclerosis plaques. Neuroradiology 2022;64:1913–14 doi:10.1007/s00234-022-03031-7 pmid:35927362

    CrossRefPubMed